Company: BLTE
Filing Date: 2025-01-27
Form Type: 424B7
Source: 0001104659-25-006367
Chunk: 2

Company: BELITE BIO, INC
Filing Date: 2025-01-27
Form: 424B7
Chunk 2
---
 SECURITIES                            | ​ | ​ | ​ | ​ | 40 | ​ | ​ |
| ​ | TAXATION                                                  | ​ | ​ | ​ | ​ | 46 | ​ | ​ |
| ​ | SELLING SHAREHOLDERS                                      | ​ | ​ | ​ | ​ | 47 | ​ | ​ |
| ​ | PLAN OF DISTRIBUTION                                      | ​ | ​ | ​ | ​ | 48 | ​ | ​ |
| ​ | WHERE YOU CAN FIND MORE INFORMATION                       | ​ | ​ | ​ | ​ | 50 | ​ | ​ |
| ​ | INCORPORATION BY REFERENCE                                | ​ | ​ | ​ | ​ | 51 | ​ | ​ |
| ​ | ENFORCEABILITY OF CIVIL LIABILITIES                       | ​ | ​ | ​ | ​ | 52 | ​ | ​ |
| ​ | LEGAL MATTERS                                             | ​ | ​ | ​ | ​ | 54 | ​ | ​ |
| ​ | EXPERTS                                                   | ​ | ​ | ​ | ​ | 55 | ​ | ​ |

S-i

TABLE OF CONTENTS

### ABOUT THIS PROSPECTUS SUPPLEMENT
**This prospectus supplement is part of a shelf registration statement and covers offered shares that may be issued by us to the selling shareholder upon the exercise by such selling shareholder of Selling Shareholder Warrants that were previously issued to such selling shareholder by us.

The selling shareholder can sell these offered shares by means of this prospectus supplement in the circumstances we describe. You should rely only on the information provided in or incorporated by reference into this prospectus supplement and the accompanying prospectus. Neither we nor the selling shareholder have authorized anyone to provide you with different or additional information. Neither we nor the selling shareholder are making an offer to sell these securities in any jurisdiction where the offer or sale of these securities is not permitted. You should not assume that the information appearing in this prospectus supplement and the accompanying prospectus or the documents incorporated by reference herein or therein is accurate as of any date other than their respective dates. Our business, financial condition, results of operations and prospects may have changed since those dates. You should read carefully the entirety of this prospectus supplement and the accompanying prospectus, as well as the documents incorporated by reference herein or therein before making an investment decision.

When we refer to “Belite,” “we,” “us,” “our,” and the “Company,” we mean Belite Bio, Inc, together with its direct and indirect wholly owned